Regulatory effects of TLR2 on megakaryocytic cell function

Blood

Volumn 117, Issue 22, 2011, Pages 5963-5974

  Beaulieu, Lea M ^a   Lin, Elaine ^a   Morin, Kristine M ^a   Tanriverdi, Kahraman ^a   Freedman, Jane E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NF E2;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL LINE; CELL MATURATION; CELL STRAIN MEG 01; CONTROLLED STUDY; DNA CONTENT; HEMOSTASIS; INFLAMMATION; MEGAKARYOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; THROMBOCYTE;

EID: 79957994822     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-304949     Document Type: Article

References (52)

1. de Sauvage FJ, Carver-Moore K, Luoh SM, et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996;183(2):651-656. (Pubitemid 26059523)
2. Pang L, Weiss MJ, Poncz M. Megakaryocyte biology and related disorders. J Clin Invest. 2005;115(12):3332-3338. (Pubitemid 43121816)
3. Kaushansky K. Historical review: megakaryopoiesis and thrombopoiesis. Blood. 2008;111(3):981-986. (Pubitemid 351213374)
4. Gordon MS, Hoffman R. Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. Blood. 1992;80(2):302-307.
5. Ishibashi T, Kimura H, Uchida T, et al. Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci U SA. 1989;86(15):5953-5957. (Pubitemid 19217566)
6. Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood. 2000;96(13):4142-4151.
7. Patel SR, Hartwig JH, Italiano JE Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest. 2005;115(12):3348-3354. (Pubitemid 43121818)
8. Kaser A, Brandacher G, Steurer W, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001;98(9):2720-2725.
9. Stohlawetz P, Folman CC, von dem Borne AE, et al. Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost. 1999;81(4):613-617.
10. Baynes RD, Bothwell TH, Flax H, et al. Reactive thrombocytosis in pulmonary tuberculosis. J Clin Pathol. 1987;40(6):676-679. (Pubitemid 17092853)
11. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17(1):1-14.
12. Medzhitov R, Preston-Hurlburt P, Kopp E, et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell. 1998;2(2):253-258. (Pubitemid 128373651)
13. Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16(1):3-9. (Pubitemid 38147427)
14. Lin E, Freedman JE, Beaulieu LM. Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases. Cardiovasc Ther. 2009;27(2):117-123.
15. Blair P, Rex S, Vitseva O, et al. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res. 2009;104(3):346-354.
16. Shiraki R, Inoue N, Kawasaki S, et al. Expression of Toll-like receptors on human platelets. Thromb Res. 2004;113(6):379-385. (Pubitemid 38844368)
17. Ward JR, Bingle L, Judge HM, et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost. 2005;94(4):831-838. (Pubitemid 41489246)
18. Aslam R, Speck ER, Kim M, et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood. 2006;107(2):637-641. (Pubitemid 43076388)
19. Ståhl AL, Svensson M, Morgelin M, et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood. 2006;108(1):167-176. (Pubitemid 43990625)
20. Rex S, Beaulieu LM, Perlman DH, et al. Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release. Thromb Haemost. 2009;102(1):97-110.
21. Thompson A, Zhang Y, Kamen D, et al. Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization. J Biol Chem. 1996;271(38):22976-22982. (Pubitemid 26314727)
22. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18(18):2195-2224.
23. Arbibe L, Mira JP, Teusch N, et al. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol. 2000;1(6):533-540.
24. Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo PH. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol. 1993;13(1):668-676. (Pubitemid 23006943)
25. Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood. 1999;93(9):2867-2875. (Pubitemid 29200777)
26. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 1995;81(5):695-704.
27. Lecine P, Villeval JL, Vyas P, et al. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood. 1998;92(5):1608-1616. (Pubitemid 28406864)
28. Raslova H, Baccini V, Loussaief L, et al. Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation. Blood. 2006;107(6):2303-2310. (Pubitemid 43345548)
29. O'Brien JJ, Spinelli SL, Tober J, et al. 15-deoxy-Delta(12,14)-PGJ(2) enhances platelet production from megakaryocytes. Blood. 2008;112(10):4051-4060.
30. Andonegui G, Kerfoot SM, McNagny K, et al. Platelets express functional Toll-like receptor-4. Blood. 2005;106(7):2417-2423. (Pubitemid 41510815)
31. Chen BC, Chang YS, Kang JC, et al. Peptidoglycan induces nuclear factor-kappaB activation and cyclooxygenase-2 expression via Ras, Raf-1, and ERK in RAW 264.7 macrophages. J Biol Chem. 2004;279(20):20889-20897.
32. Pathak SK, Bhattacharyya A, Pathak S, et al. Tolllike receptor 2 and mitogen- and stress-activated kinase 1 are effectors of Mycobacterium aviuminduced cyclooxygenase-2 expression in macrophages. J Biol Chem. 2004;279(53):55127-55136. (Pubitemid 40066506)
33. Hazeki K, Nigorikawa K, Hazeki O. Role of phosphoinositide 3-kinase in innate immunity. Biol Pharm Bull. 2007;30(9):1617-1623. (Pubitemid 47403233)
34. Wain J, Pham VB, Ha V, et al. Quantitation of bacteria in bone marrow from patients with typhoid fever: relationship between counts and clinical features. J Clin Microbiol. 2001;39(4):1571-1576. (Pubitemid 32275468)
35. Towatari M, Ciro M, Ottolenghi S, Tsuzuki S, Enver T. Involvement of mitogen-activated protein kinase in the cytokine-regulated phosphorylation of transcription factor GATA-1. Hematol J. 2004;5(3):262-272. (Pubitemid 38931333)
36. Kadri Z, Maouche-Chretien L, Rooke HM, et al. Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation. Mol Cell Biol. 2005;25(17):7412-7422. (Pubitemid 41170105)
37. Tsang AP, Visvader JE, Turner CA, et al. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell. 1997;90(1):109-119. (Pubitemid 28009423)
38. Lee TL, Shyu YC, Hsu PH, et al. JNK-mediated turnover and stabilization of the transcription factor p45/NF-E2 during differentiation of murine erythroleukemia cells. Proc Natl Acad Sci U S A. 2010;107(1):52-57.
39. Guerriero R, Parolini I, Testa U, et al. Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes. J Cell Sci. 2006;119(Pt 4):744-752.
40. Sekulić A, Hudson CC, Homme JL, et al. A direct linkage between the phosphoinositide 3-kinase- AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 2000;60(13):3504-3513. (Pubitemid 30482170)
41. Wang Y, Rangan GK, Tay YC, Harris DC. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol. 1999;10(6):1204-1213. (Pubitemid 29246985)
42. Chen J, Zhao M, Rao R, Inoue H, Hao CM. C/EBP{beta} and its binding element are required for NF{kappa}B-induced COX2 expression following hypertonic stress. J Biol Chem. 2005;280(16):16354-16359. (Pubitemid 40616764)
43. Wang T, Lafuse WP, Zwilling BS. NFkappaB and Sp1 elements are necessary for maximal transcription of toll-like receptor 2 induced by Mycobacterium avium. J Immunol. 2001;167(12):6924-6932. (Pubitemid 33144186)
44. Bian ZM, Elner SG, Yoshida A, Elner VM. Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression. Invest Ophthalmol Vis Sci. 2004;45(6):1887-1896. (Pubitemid 38868986)
45. Dos Santos S, Delattre AI, De Longueville F, Bult H, Raes M. Gene expression profiling of LPS-stimulated murine macrophages and role of the NF-kappaB and PI3K/mTOR signaling pathways. Ann N Y Acad Sci. 2007;1096:70-77. (Pubitemid 47092499)
46. Ni CW, Wang DL, Lien SC, et al. Activation of PKC-epsilon and ERK1/2 participates in shear-induced endothelial MCP-1 expression that is repressed by nitric oxide. J Cell Physiol. 2003;195(3):428-344.
47. Jang BC, Jung TY, Paik JH, et al. Tetradecanoyl phorbol acetate induces expression of Toll-like receptor 2 in U937 cells: involvement of PKC, ERK, and NF-kappaB. Biochem Biophys Res Commun. 2005;328(1):70-77.
48. Rocca B, Secchiero P, Ciabattoni G, et al. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci U S A. 2002;99(11):7634-7639. (Pubitemid 34568743)
49. Tanaka N, Sato T, Fujita H, Morita I. Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis. Arterioscler Thromb Vasc Biol. 2004;24(3):607-612. (Pubitemid 38326160)
50. Sevinsky JR, Whalen AM, Ahn NG. Extracellular signal-regulated kinase induces the megakaryocyte GPIIb/CD41 gene through MafB/Kreisler. Mol Cell Biol. 2004;24(10):4534-4545. (Pubitemid 44109136)
51. Ludlow LB, Schick BP, Budarf ML, et al. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibbeta promoter resulting in the Bernard-Soulier syndrome. J Biol Chem. 1996;271(36):22076-22080. (Pubitemid 26303836)
52. Massoudy P, Zahler S, Becker BF, et al. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest. 2001;119(1):31-36. (Pubitemid 32150544)